Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1388891-97-1

C14H20N4S is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1388891-97-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1388891-97-1 Structure

  • Basic information

    1. Product Name: C14H20N4S
    2. Synonyms: C14H20N4S
    3. CAS NO:1388891-97-1
    4. Molecular Formula:
    5. Molecular Weight: 276.406
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1388891-97-1.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: C14H20N4S(CAS DataBase Reference)
    10. NIST Chemistry Reference: C14H20N4S(1388891-97-1)
    11. EPA Substance Registry System: C14H20N4S(1388891-97-1)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1388891-97-1(Hazardous Substances Data)

1388891-97-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1388891-97-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,8,8,8,9 and 1 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1388891-97:
(9*1)+(8*3)+(7*8)+(6*8)+(5*8)+(4*9)+(3*1)+(2*9)+(1*7)=241
241 % 10 = 1
So 1388891-97-1 is a valid CAS Registry Number.

1388891-97-1Relevant articles and documents

IRAK INHIBITORS AND USES THEREOF

-

, (2012/07/28)

The present invention relates to compounds and methods useful for inhibiting one or more interleukin-l receptor-associated kinases ("IRAK"). In some embodiments, a provided compound inhibits IRAK-1 and IRAK-4. The invention also provides pharmaceutically acceptable compositions comprising compounds of the present invention and methods of using said compositions in the treatment of various disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1388891-97-1